We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWBC icon
526
East-West Bancorp
EWBC
$18.2B
$28M 0.03%
424,282
-1,416
-0.3% -$96.9K
SNPS icon
527
Synopsys
SNPS
$78.6B
$27.9M 0.03%
87,305
-13,514
-13% -$4.23M
HDV
528
iShares Core High Dividend ETF
HDV
$15B
$27.9M 0.03%
1,336,510
+17,750
+1% +$363K
CHD icon
529
Church & Dwight Co
CHD
$24.4B
$27.8M 0.03%
345,012
+442
+0.1% +$33.9K
COF icon
530
Capital One
COF
$135B
$27.8M 0.03%
299,043
-2,069
-0.7% -$203K
AWK icon
531
American Water Works
AWK
$26.9B
$27.8M 0.03%
182,232
+3,459
+2% +$499K
NTRS icon
532
Northern Trust
NTRS
$34.6B
$27.7M 0.03%
312,523
+31,167
+11% +$2.73M
FTNT icon
533
Fortinet
FTNT
$119B
$27.6M 0.03%
564,936
-38,670
-6% -$2.02M
DOV icon
534
Dover
DOV
$28.1B
$27.6M 0.03%
203,930
-814
-0.4% -$108K
VOE icon
535
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$27.5M 0.03%
203,656
-13,632
-6% -$1.83M
AXS icon
536
AXIS Capital
AXS
$7.39B
$27.5M 0.03%
506,770
-965
-0.2% -$52.1K
CGXU icon
537
Capital Group International Focus Equity ETF
CGXU
$6.54B
$27.3M 0.03%
1,311,990
+365,333
+39% +$7.48M
EXPD icon
538
Expeditors International
EXPD
$23.1B
$27.3M 0.03%
262,691
+2,996
+1% +$309K
CMS icon
539
CMS Energy
CMS
$21.8B
$27.2M 0.03%
430,112
+3,820
+0.9% +$226K
IDXX icon
540
Idexx Laboratories
IDXX
$46.6B
$27.2M 0.03%
66,751
-1,347
-2% -$523K
SPLV icon
541
Invesco S&P 500 Low Volatility ETF
SPLV
$7.18B
$27.2M 0.03%
425,962
-16,983
-4% -$1.05M
ULTA icon
542
Ulta Beauty
ULTA
$23.3B
$27.1M 0.02%
57,738
+985
+2% +$425K
ARKK icon
543
ARK Innovation ETF
ARKK
$6.37B
$27.1M 0.02%
866,427
-215,347
-20% -$7.7M
CNI icon
544
Canadian National Railway
CNI
$76.1B
$27.1M 0.02%
227,630
+995
+0.4% +$119K
GGG icon
545
Graco
GGG
$13.6B
$26.9M 0.02%
400,548
-6,829
-2% -$455K
GBCI icon
546
Glacier Bancorp
GBCI
$6.39B
$26.8M 0.02%
542,336
+12,130
+2% +$654K
TROW icon
547
T. Rowe Price
TROW
$24.4B
$26.6M 0.02%
244,152
-163,079
-40% -$18.5M
ALB icon
548
Albemarle
ALB
$15.3B
$26.5M 0.02%
122,271
+10,126
+9% +$2.7M
MDC
549
DELISTED
M.D.C. Holdings, Inc.
MDC
$26.3M 0.02%
833,810
-71,380
-8% -$2.21M
CNC icon
550
Centene
CNC
$32.4B
$26.3M 0.02%
320,729
-29,873
-9% -$2.44M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.